BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

GenScript Biotech Hosts European Debut of Global Forum, Driving Collaboration in Cell and Gene Therapy Innovation

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the European debut of its GenS...

November 22, 2024 | Report

Samsung Biologics Secures USD 668 Million in Manufacturing Deals with Europe, Surpasses USD 4 Billion in 2024 Global Contract Value

The company will provide manufacturing services through 2031 in deals worth over USD 668 million Samsung Biologics' cumulative contract value for 2...

November 20, 2024 | News

South Korea’s Celltrion Acquires iQone Healthcare Switzerland to Boost Direct Commercialization of Biosimilars in Europe

Celltrion announces acquisition of iQone Healthcare Switzerland, accelerating direct commercialization of its biosimilars in the European region T...

November 18, 2024 | News

SEKISUI Diagnostics Completes £15.7 Million cGMP Expansion for Enhanced Microbial Drug Substance Manufacturing in the UK

SEKISUI Diagnostics' microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion&nbs...

November 15, 2024 | News

Australia’s Aravax Establishes UK Subsidiary to Advance Allergy Immunotherapies

Aravax, a clinical-stage biotechnology company developing next-generation immunotherapies designed to be safe, convenient, and precisely targeted, today an...

November 14, 2024 | News

DEBx Medical Secures New Investment Round Led by TVM Capital Healthcare to Accelerate Expansion in Europe, MENA, and Global Markets

DEBx Medical, an Amsterdam-based leader in advanced wound care, has announced the successful completion of its second investment round, spearheaded by TVM ...

November 14, 2024 | News

BioApp Solutions Boosts Productivity and Reproducibility with INTEGRA Biosciences’ Pipettes

INTEGRA Biosciences’ pipettes are being used by bioanalytical consultancy BioApp Solutions to semi-automate and streamline its repetitive liquid...

November 14, 2024 | News

Taiwan's Caliway Biopharmaceuticals Receives EMA Orphan Drug Designation for CBL-514 in Dercum’s Disease Treatment

CBL-514 is the first and only drug to receive EMA Orphan Drug Designation for Dercum's disease treatment.- CBL-514 received both FDA Orphan Drug...

November 14, 2024 | News

Hospital de Sant Pau and Huawei Present Joint Vision for Digital Transformation in Healthcare

Industry Leaders from Hospital de Sant Pau and Huawei today outlined a vision of how digital technology can make hospitals more efficient and improve...

November 13, 2024 | News

Ascend Advanced Therapies Partners with EW Healthcare to Bolster US Footprint and Integrate ABL’s Expertise in Viral Vector Manufacturing

Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, has partnered with EW Healthcare Partners to expand the footprint and capa...

November 13, 2024 | News

Lonza Expands Bioconjugation Capabilities in Switzerland with New Manufacturing Suites

The expansion of bioconjugation capabilities will provide additional manufacturing capacity for launch and commercial supply, addressing growing market...

November 12, 2024 | News

Nordic Bioscience Secures FDA Letter of Support for CPa9-HNE Biomarker in Advancing IBD Clinical Trials

Nordic Bioscience, a leading biomarker company, announced that its CPa9-HNE biomarker assay received a Letter of Support (LoS) from the U.S. Food and Drug ...

November 12, 2024 | News

Australia’s Neurizon Therapeutics Secures Positive EMA Opinion for Orphan Medicinal Product Designation of NUZ-001 in ALS

Notice of positive opinion received from the European Medicines Agency for Orphan Medicinal Product Designation for NUZ-001 in Amyotrophic Lateral S...

November 12, 2024 | News

Harbour BioMed Files IND Application in China for Novel Antibody Therapy HBM9378/SKB378 Targeting COPD

Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel ant...

November 11, 2024 | News

Stay Connected